Scandion Oncology A/S
SCOL | ST
Overview
Corporate Details
- ISIN(s):
- DK0061031895 (+3 more)
- LEI:
- 549300MPWDMQ5LZEGD09
- Country:
- Denmark
- Address:
- Fruebjergvej 3, 2100 København Ø
- Website:
- https://scandiononcology.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Scandion Oncology A/S is a company under liquidation. Previously, it operated as a clinical-stage biotechnology company focused on overcoming cancer drug resistance. The company's mission was to develop first-in-class, oral add-on drugs to revert resistance to existing cancer treatments and improve patient outcomes. Its primary development asset was the lead compound SCO-101, which aimed to enhance the efficacy of chemotherapy in patients who had developed treatment resistance. The company's research was centered on creating a pipeline of drugs targeting various molecular drug resistance mechanisms in cancer cells.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Scandion Oncology A/S.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all Scandion Oncology A/S filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Scandion Oncology A/S via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
